Skip to content

post spinal headache relieved by intranasal block

Comparative evaluation of conservative management and sphenopalatine ganglion block for post dural puncture headache: a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/011883
Enrollment
60
Registered
2018-02-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA grade 1 and 2

Interventions

Intervention1: 1. Lignocaine 1.5 cc of 4% 2.lignocaine 10% spray 3.paracetamol tablet: 1.lignocaine 1.5 cc of 4% in each nostril 2.lignocaine 10% spray -2 puffs in each nostril 3.paracetamol 650 mg C

Sponsors

Department of anaesthesiology
Lead Sponsor
Dr Raman kumar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.patients of ASA physical status 1,2 2.age between 18-60 Years of age of either sex 3.able to comprehend and willing to participate 4.experiencing a Post Dural puncture headche within seven days of dural puncture. 5.VAS score >3

Exclusion criteria

Exclusion criteria: 1. 60 years of age 2.VAS score on presentation less than or equal to 10 for headache. 3.known coagulopathy 4.known nasal septal deviation or abnormalities such as polyps. 5.any history of sinusitis,rhinitis,migraine,cluster headache.

Design outcomes

Primary

MeasureTime frame
Relieve of headache after conservative management and sphenopalatine ganglion block.Timepoint: From onset of headache to relieve of headache after conservative management or sphenopalatine ganglion block uoto 7 days

Secondary

MeasureTime frame
Satisfaction of patientsTimepoint: From onset of headache to relive of headache after conservative management or sphenopalatine ganglion block upto 7 days.

Countries

India

Contacts

Public ContactRaman kumar

INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES, PATNA

drvvinodv@gmail.com7481970365

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 19, 2026